IM Cannabis closes non-brokered private placement of common shares

1 minute read
05 October 2022

Between August 24 and October 5, 2022, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) completed multiple tranches of a non-brokered private placement of common shares of the company for aggregate proceeds of approximately US$3 million.

IM Cannabis is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers, and is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. 

Gowling WLG advised IM Cannabis with respect to this private placement with a team that included Peter Simeon, Josh Almario, Josh Rosen and Sean Walsh.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.